Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid LeukemiaCourtney D. DiNardo, Hagop M. Kantarjian, Naval Daver et al.|Journal of Clinical Oncology|2021Cited by 333
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i> -Mutated Myeloid MalignanciesCurtis A. Lachowiez, Courtney D. DiNardo, Sanam Loghavi et al.|Blood Cancer Discovery|2023Cited by 122
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AMLCurtis A. Lachowiez, Daniel A. Pollyea, Vishvaas I Ravikumar et al.|Blood|2024Cited by 30